Citations (81)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Dainik Patel, David Chan, Gabrielle Cehic, Nick Pavlakis & Timothy Jay Price. (2016) Systemic therapies for advanced gastroenteropancreatic neuroendocrine tumors. Expert Review of Endocrinology & Metabolism 11:4, pages 311-327.
Read now
Read now
Muhammad Wasif Saif. (2016) Lanreotide for the treatment of gastroenteropancreatic neuroendocrine tumors. Expert Opinion on Pharmacotherapy 17:3, pages 443-456.
Read now
Read now
Ludovica FS Grasso, Renata S Auriemma, Rosario Pivonello & Annamaria Colao. (2015) Adverse events associated with somatostatin analogs in acromegaly. Expert Opinion on Drug Safety 14:8, pages 1213-1226.
Read now
Read now
Miao Hu & Brian Tomlinson. (2010) Pharmacokinetic evaluation of lanreotide. Expert Opinion on Drug Metabolism & Toxicology 6:10, pages 1301-1312.
Read now
Read now
Articles from other publishers (77)
Alastair J. Gemmell, Colin M. Brown, Surajit Ray & Alexander Small. (2023) Quantitative uptake in 99mTc-EDDA/HYNIC-TOC somatostatin receptor imaging – the effect of long-acting release somatostatin analogue therapy. Nuclear Medicine Communications.
Crossref
Crossref
Yue Cheng, Lowell Anthony, Chris Delcher, Daniela C Moga, Aman Chauhan, Bin Huang & Val Adams. (2023) Prescribing Characteristics of Octreotide Immediate-Release and Long-Acting Release in Patients with Neuroendocrine Tumors. The Oncologist 28:6, pages 479-485.
Crossref
Crossref
V. T. Ivanov & V. I. Deigin. (2023) Evolution of Peptide Drug Biopharmaceutics. Russian Journal of Bioorganic Chemistry 49:3, pages 422-434.
Crossref
Crossref
Silvia Gervasoni, Camilla Guccione, Viviana Fanti, Andrea Bosin, Giancarlo Cappellini, Bruno Golosio, Paolo Ruggerone & Giuliano Malloci. (2023) Molecular simulations of SSTR2 dynamics and interaction with ligands. Scientific Reports 13:1.
Crossref
Crossref
Tomoki Takeuchi, Yusaku Nomura, Tomoko Tamita, Rie Nishikawa, Hiroyuki Kakinuma, Naoki Kojima, Kosuke Hitaka, Yunoshin Tamura, Masafumi Kamitani, Masashi Mima, Akiko Nozoe & Masato Hayashi. (2023) Discovery of TP0597850: A Selective, Chemically Stable, and Slow Tight-Binding Matrix Metalloproteinase-2 Inhibitor with a Phenylbenzamide–Pentapeptide Hybrid Scaffold. Journal of Medicinal Chemistry 66:1, pages 822-836.
Crossref
Crossref
Vyacheslav S. Pronin, Mikhail B. Antsiferov, Tatiana M. Alexeeva & Evgeny V. Pronin. (2022) Targeted treatment with somatostatin analogues: widening horizons of clinical practice. Almanac of Clinical Medicine 50:3, pages 196-204.
Crossref
Crossref
Emre Gezer, Yeliz Demirhan, Alev Selek, Zeynep Cantürk, Berrin Çetinarslan, Mehmet Sözen, Damla Köksalan & Ayfer Peker Karatoprak. (2022) Comparison between somatostatin analog injections. Revista da Associação Médica Brasileira 68:4, pages 514-518.
Crossref
Crossref
Iris Bea L. Ramiro, Walden E. Bjørn-Yoshimoto, Julita S. ImperialJoanna Gajewiak, Paula Flórez Salcedo, Maren Watkins, Dylan Taylor, William Resager, Beatrix Ueberheide, Hans Bräuner-Osborne, Frank G. WhitbyChristopher P. Hill, Laurent F. Martin, Amol Patwardhan, Gisela P. ConcepcionBaldomero M. Olivera & Helena Safavi-Hemami. (2022) Somatostatin venom analogs evolved by fish-hunting cone snails: From prey capture behavior to identifying drug leads. Science Advances 8:12.
Crossref
Crossref
Alejandro Mejia, Elaina Vivian, Christiana Nwogu, Jimmy Shah, Raquel Longoria, Allison Vo, Islam Shahin, Jonathan Verma & Alexandru Bageac. (2022) Peptide receptor radionuclide therapy implementation and results in a predominantly gastrointestinal neuroendocrine tumor population. Medicine 101:9, pages e28970.
Crossref
Crossref
Ahil N. Ganesh, Sudhakar Garad & Manuel V. Sanchez-Felix. 2022. Oral Delivery of Therapeutic Peptides and Proteins. Oral Delivery of Therapeutic Peptides and Proteins
87
130
.
Larry R. Brown. 2022. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays
1
27
.
Gustavo Rocha, Vanessa Arnet, Paulo Soares, Ana Cristina Gomes, Sandra Costa, Paula Guerra, Jorge Casanova & Inês Azevedo. (2021) Chylothorax in the neonate—A stepwise approach algorithm. Pediatric Pulmonology 56:10, pages 3093-3105.
Crossref
Crossref
Lowell B. Anthony & Thomas M. O'Dorisio. (2021) Opportunities to Improve Symptom Control with Somatostatin Congeners in GEP-NETs: A Review of Key Issues. The Oncologist 26:7, pages e1171-e1178.
Crossref
Crossref
Benjamin D. McNeil. (2021) Minireview: Mas-related G protein-coupled receptor X2 activation by therapeutic drugs. Neuroscience Letters 751, pages 135746.
Crossref
Crossref
Mengshi Li, Edwin A. Sagastume, Dongyoul Lee, Daniel McAlister, Anthony J. DeGraffenreid, Keith R. Olewine, Stephen Graves, Roy Copping, Saed Mirzadeh, Brian E. Zimmerman, Roy H. Larsen, Frances L. Johnson & Michael K. Schultz. (2020) 203/212Pb Theranostic Radiopharmaceuticals for Image-guided Radionuclide Therapy for Cancer. Current Medicinal Chemistry 27:41, pages 7003-7031.
Crossref
Crossref
Romain Eychenne, Christelle Bouvry, Mickael Bourgeois, Pascal Loyer, Eric Benoist & Nicolas Lepareur. (2020) Overview of Radiolabeled Somatostatin Analogs for Cancer Imaging and Therapy. Molecules 25:17, pages 4012.
Crossref
Crossref
Brigitte Delemer, Thierry Nguyen-Tan-Hon, Romain Coriat, Denis Smith, Frank Schillo, Isabelle Raingeard, Iradj Sobhani, Pierre-Luc Etienne, Benedicte Decoudier, Ségolène Bisot-Locard, Alexandre Santos, Gerald Raverot & Guillaume Cadiot. (2020) Evaluation of Nurses’ and Patients’ Overall Satisfaction with New and Previous Formulations of Octreotide Long-acting Release (Sandostatin LAR®): A French Observational Study. Advances in Therapy 37:9, pages 3901-3915.
Crossref
Crossref
Anthony P. Davenport, Conor C. G. Scully, Chris de Graaf, Alastair J. H. Brown & Janet J. Maguire. (2020) Advances in therapeutic peptides targeting G protein-coupled receptors. Nature Reviews Drug Discovery 19:6, pages 389-413.
Crossref
Crossref
Tianpei Li, Reuban Toby D’Cruz, Sheng Yang Lim & Vishal G. Shelat. (2020) Somatostatin analogues and the risk of post-operative pancreatic fistulas after pancreatic resection - A systematic review & meta-analysis. Pancreatology 20:2, pages 158-168.
Crossref
Crossref
Aleksandra Bocian & Konrad K. Hus. (2019) Antibacterial properties of snake venom components. Chemical Papers 74:2, pages 407-419.
Crossref
Crossref
Basma Haris, Saras Saraswathi & Khalid Hussain. (2020) Somatostatin analogues for the treatment of hyperinsulinaemic hypoglycaemia. Therapeutic Advances in Endocrinology and Metabolism 11, pages 204201882096506.
Crossref
Crossref
Jonathan Wang, Nirmalya Tripathy & Eun Ji Chung. (2020) Targeting and therapeutic peptide-based strategies for polycystic kidney disease. Advanced Drug Delivery Reviews 161-162, pages 176-189.
Crossref
Crossref
L. B. Markin & K. L. Shatylovych. (2019) Pregnancy management in patients with acromegaly. Reproductive Endocrinology 0:49, pages 24-28.
Crossref
Crossref
Mariangela Torniai, Laura Scortichini, Francesca Tronconi, Corrado Rubini, Francesca Morgese, Silvia Rinaldi, Paola Mazzanti & Rossana Berardi. (2019) Systemic treatment for lung carcinoids: from bench to bedside. Clinical and Translational Medicine 8:1.
Crossref
Crossref
C. Shaun Loveless, Lauren L. Radford, Samuel J. Ferran, Stacy L. Queern, Matthew R. Shepherd & Suzanne E. Lapi. (2019) Photonuclear production, chemistry, and in vitro evaluation of the theranostic radionuclide 47Sc. EJNMMI Research 9:1.
Crossref
Crossref
Julie Guilmette & Vânia Nosé. (2019) Paraneoplastic syndromes and other systemic disorders associated with neuroendocrine neoplasms. Seminars in Diagnostic Pathology 36:4, pages 229-239.
Crossref
Crossref
Sara Pusceddu, Natalie Prinzi, Alessandra Raimondi, Francesca Corti, Roberto Buzzoni, Maria Di Bartolomeo, Ettore Seregni, Marco Maccauro, Jorgelina Coppa, Massimo Milione, Vincenzo Mazzaferro & Filippo de Braud. (2018) Entering the third decade of experience with octreotide LAR in neuroendocrine tumors: A review of current knowledge. Tumori Journal 105:2, pages 113-120.
Crossref
Crossref
Franca Dicuonzo, Stefano Purciariello, Aurora De Marco, Edoardo Guastamacchia & Vicenzo Triggiani. (2019) Inoperable Giant Growth Hormone-secreting Pituitary Adenoma: Radiological Aspects, Clinical Management and Pregnancy Outcome. Endocrine, Metabolic & Immune Disorders - Drug Targets 19:2, pages 214-220.
Crossref
Crossref
Marianne Pavel, Françoise Borson-Chazot, Anne Cailleux, Dieter Hörsch, Harald Lahner, Rosario Pivonello, Libuse Tauchmanova, Christelle Darstein, Håkan Olsson, Fredrik Tiberg & Diego Ferone. (2018) Octreotide SC depot in patients with acromegaly and functioning neuroendocrine tumors: a phase 2, multicenter study. Cancer Chemotherapy and Pharmacology 83:2, pages 375-385.
Crossref
Crossref
Michelle A.O. Kinney, David M. Nagorney, Daniel F. Clark, Travis D. O'Brien, Jonathan D. Turner, Mary E. Marienau, Darrell R. Schroeder & David P. Martin. (2018) Partial hepatic resections for metastatic neuroendocrine tumors: perioperative outcomes. Journal of Clinical Anesthesia 51, pages 93-96.
Crossref
Crossref
Paul Benjamin Loughrey, Dongyun Zhang & Anthony P. Heaney. (2018) New Treatments for the Carcinoid Syndrome. Endocrinology and Metabolism Clinics of North America 47:3, pages 557-576.
Crossref
Crossref
Rosario Pivonello, Giovanna Muscogiuri, Geoffrey Holder, Michaela Paul, Severine Sarp, Anastasia Lesogor, Pierre Jordaan, Johannes Eisinger & Annamaria Colao. (2017) Long-term safety of long-acting octreotide in patients with diabetic retinopathy: results of pooled data from 2 randomized, double-blind, placebo-controlled phase 3 studies. Endocrine 60:1, pages 65-72.
Crossref
Crossref
Rosa Maria Paragliola & Roberto Salvatori. (2018) Novel Somatostatin Receptor Ligands Therapies for Acromegaly. Frontiers in Endocrinology 9.
Crossref
Crossref
Antoine Henninot, James C. Collins & John M. Nuss. (2017) The Current State of Peptide Drug Discovery: Back to the Future?. Journal of Medicinal Chemistry 61:4, pages 1382-1414.
Crossref
Crossref
Heike Corda, Sebastian Kummer, Alena Welters, Norbert Teig, Dirk Klee, Ertan Mayatepek & Thomas Meissner. (2017) Treatment with long-acting lanreotide autogel in early infancy in patients with severe neonatal hyperinsulinism. Orphanet Journal of Rare Diseases 12:1.
Crossref
Crossref
Venkat Vuddanda, Mohammad-Ali Jazayeri, Mohit K. Turagam, Madhav Lavu, Valay Parikh, Donita Atkins, Sudharani Bommana, Madhu Reddy Yeruva, Luigi Di Biase, Jie Cheng, Vijay Swarup, Rakesh Gopinathannair, Mojtaba Olyaee, Vijay Ivaturi, Andrea Natale & Dhanunjaya Lakkireddy. (2017) Systemic Octreotide Therapy in Prevention of Gastrointestinal Bleeds Related to Arteriovenous Malformations and Obscure Etiology in Atrial Fibrillation. JACC: Clinical Electrophysiology 3:12, pages 1390-1399.
Crossref
Crossref
Chao Deng, Bo Deng, Liqun Jia & Huangying Tan. (2017) Efficacy of long-acting release octreotide for preventing chemotherapy-induced diarrhoea: protocol for a systematic review. BMJ Open 7:6, pages e014916.
Crossref
Crossref
Ramar Perumal Samy, Bradley G. Stiles, Octavio L. Franco, Gautam Sethi & Lina H.K. Lim. (2017) Animal venoms as antimicrobial agents. Biochemical Pharmacology 134, pages 127-138.
Crossref
Crossref
Stacy S. Tse & Troy Kish. (2017) Octreotide-Associated Neutropenia. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37:6, pages e32-e37.
Crossref
Crossref
Yusuf A. Haggag, Kyle B. Matchett, El-Habib Dakir, Paul Buchanan, Mohammed A. Osman, Sanaa A. Elgizawy, Mohamed El-Tanani, Ahmed M. Faheem & Paul A. McCarron. (2017) Nano-encapsulation of a novel anti-Ran-GTPase peptide for blockade of regulator of chromosome condensation 1 (RCC1) function in MDA-MB-231 breast cancer cells. International Journal of Pharmaceutics 521:1-2, pages 40-53.
Crossref
Crossref
Nir Qvit, Samuel J.S. Rubin, Travis J. Urban, Daria Mochly-Rosen & Eric R. Gross. (2017) Peptidomimetic therapeutics: scientific approaches and opportunities. Drug Discovery Today 22:2, pages 454-462.
Crossref
Crossref
Benxia YuZhongsheng ZhangHao SongYuchun ChiChunling ShiMiao Xu. (2017) Clinical Importance of Somatostatin Receptor 2 (SSTR2) and Somatostatin Receptor 5 (SSTR5) Expression in Thyrotropin-Producing Pituitary Adenoma (TSHoma). Medical Science Monitor 23, pages 1947-1955.
Crossref
Crossref
J-M. Ahn, K. Kassees, T-K. Lee, B. Manandhar & A.M. Yousif. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
66
115
.
Alexandria T. Phan & Bhuvanesh Dave. (2016) The pivotal role of mammalian target of rapamycin inhibition in the treatment of patients with neuroendocrine tumors. Cancer Medicine 5:10, pages 2953-2964.
Crossref
Crossref
Eric L. Schneider, Jeff Henise, Ralph Reid, Gary W. Ashley & Daniel V. Santi. (2016) Subcutaneously Administered Self-Cleaving Hydrogel–Octreotide Conjugates Provide Very Long-Acting Octreotide. Bioconjugate Chemistry 27:7, pages 1638-1644.
Crossref
Crossref
Mengxin Wang, Fengying Shan, Yang Zou, Xun Sun, Zhi-Rong Zhang, Yao Fu & Tao Gong. (2016) Pharmacokinetic and pharmacodynamic study of a phospholipid-based phase separation gel for once a month administration of octreotide. Journal of Controlled Release 230, pages 45-56.
Crossref
Crossref
Chan Shen, Ying Xu, Arvind Dasari, Ya-Chen Tina Shih & James C. Yao. (2016) Octreotide LAR Dosage and Survival Among Elderly Patients With Distant-Stage Neuroendocrine Tumors. The Oncologist 21:3, pages 308-313.
Crossref
Crossref
Ariane F. Lacerda, Patrícia B. Pelegrini, Daiane M. de Oliveira, Érico A. R. Vasconcelos & Maria F. Grossi-de-Sá. (2016) Anti-parasitic Peptides from Arthropods and their Application in Drug Therapy. Frontiers in Microbiology 7.
Crossref
Crossref
Anjie YangJocelyn BrownErnie Mak. (2016) Persistent Diarrhea after Celiac Plexus Block in a Pancreatic Cancer Patient: Case Report and Literature Review. Journal of Palliative Medicine 19:1, pages 83-86.
Crossref
Crossref
Daniel A. Richards, Sally A. Fletcher, Muriel Nobles, Hanno Kossen, Lauren Tedaldi, Vijay Chudasama, Andrew Tinker & James R. Baker. (2016) Photochemically re-bridging disulfide bonds and the discovery of a thiomaleimide mediated photodecarboxylation of C-terminal cysteines. Organic & Biomolecular Chemistry 14:2, pages 455-459.
Crossref
Crossref
Anthony M. Magliocco. 2016. Neuroendocrine Tumors: Review of Pathology, Molecular and Therapeutic Advances. Neuroendocrine Tumors: Review of Pathology, Molecular and Therapeutic Advances
437
444
.
Aman Chauhan & Robert A. Ramirez. (2015) Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) and the Role of Somatostatin analogs: A Case Series. Lung 193:5, pages 653-657.
Crossref
Crossref
Fredrik Tiberg, John Roberts, Camilla Cervin, Markus Johnsson, Severine Sarp, Anadya Prakash Tripathi & Margareta Linden. (2015) Octreotide s.c. depot provides sustained octreotide bioavailability and similar IGF‐1 suppression to octreotide LAR in healthy volunteers. British Journal of Clinical Pharmacology 80:3, pages 460-472.
Crossref
Crossref
Nuno Vale, LuÃsa Aguiar & Paula Gomes. (2014) Antimicrobial peptides: a new class of antimalarial drugs?. Frontiers in Pharmacology 5.
Crossref
Crossref
Mounira Chalabi, Camille Duluc, Philippe Caron, Delphine Vezzosi, Julie Guillermet-Guibert, Stéphane Pyronnet & Corinne Bousquet. (2014) Somatostatin analogs: does pharmacology impact antitumor efficacy?. Trends in Endocrinology & Metabolism 25:3, pages 115-127.
Crossref
Crossref
Hidenori FUKUOKA & Yutaka TAKAHASHI. (2014) The Role of Genetic and Epigenetic Changes in Pituitary Tumorigenesis. Neurologia medico-chirurgica 54:12, pages 943-957.
Crossref
Crossref
Volker H. Schartinger, József Dudás, Clemens Decristoforo, Christoph Url, Johannes Schnabl, Georg Göbel, Irene J. Virgolini, Herbert Riechelmann, Michael Rasse, Dietmar Waitz & Daniel Putzer. (2013) 68Ga-DOTA0-Tyr3-octreotide positron emission tomography in head and neck squamous cell carcinoma. European Journal of Nuclear Medicine and Molecular Imaging 40:9, pages 1365-1372.
Crossref
Crossref
Marily Theodoropoulou & Günter K. Stalla. (2013) Somatostatin receptors: From signaling to clinical practice. Frontiers in Neuroendocrinology 34:3, pages 228-252.
Crossref
Crossref
Edward M. Wolin, Ke Hu, Gareth Hughes, Emmanuel Bouillaud, Vanessa Giannone & Karina Hermosillo Resendiz. (2013) Safety, tolerability, pharmacokinetics, and pharmacodynamics of a long-acting release (LAR) formulation of pasireotide (SOM230) in patients with gastroenteropancreatic neuroendocrine tumors: results from a randomized, multicenter, open-label, phase I study. Cancer Chemotherapy and Pharmacology 72:2, pages 387-395.
Crossref
Crossref
Valeria Giandomenico, Irvin M. Modlin, Fredrik Pontén, Mats Nilsson, Ulf Landegren, Jonas Bergqvist, Mohid S. Khan, Robert P. Millar, Bengt Långström, Jürgen Borlak, Barbro Eriksson, Bengt Nielsen, Lars Baltzer, John C. Waterton, Håkan Ahlström & Kjell Öberg. (2013) Improving the Diagnosis and Management of Neuroendocrine Tumors: Utilizing New Advances in Biomarker and Molecular Imaging Science. Neuroendocrinology 98:1, pages 16-30.
Crossref
Crossref
Larry R. Brown. 2013. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays
677
690
.
V H Schartinger, C Falkeis, K Laimer, G M Sprinzl, H Riechelmann, M Rasse, I Virgolini & J Dudás. (2012) Neuroendocrine differentiation in head and neck squamous cell carcinoma. The Journal of Laryngology & Otology 126:12, pages 1261-1270.
Crossref
Crossref
Belén Hernández, Yves-Marie Coïc, Sergei G. Kruglik, Claude Carelli, Régis Cohen & Mahmoud Ghomi. (2012) Octreotide Used for Probing the Type-II′ β-Turn CD and Raman Markers. The Journal of Physical Chemistry B 116:31, pages 9337-9345.
Crossref
Crossref
Áron Roxin & Gang Zheng. (2012) Flexible or fixed: a comparative review of linear and cyclic cancer-targeting peptides. Future Medicinal Chemistry 4:12, pages 1601-1618.
Crossref
Crossref
H. Dietrich, K. Hu, M. Ruffin, D. Song, E. Bouillaud, Y. Wang & J. Hasskarl. (2012) Safety, tolerability, and pharmacokinetics of a single dose of pasireotide long-acting release in healthy volunteers: a single-center Phase I study. European Journal of Endocrinology 166:5, pages 821-828.
Crossref
Crossref
Nancy M. Gardner-Roehnelt. (2012) Update on the Management of Neuroendocrine Tumors: Focus on Somatostatin Antitumor Effects. Clinical Journal of Oncology Nursing 16:1, pages 56-64.
Crossref
Crossref
Nazila Kamaly, Zeyu Xiao, Pedro M. Valencia, Aleksandar F. Radovic-Moreno & Omid C. Farokhzad. (2012) Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chemical Society Reviews 41:7, pages 2971.
Crossref
Crossref
Yun-Seok Rhee, MinJi Sohn, Byung H. Woo, B. C. Thanoo, Patrick P. DeLuca & Heidi M. Mansour. (2011) Sustained-Release Delivery of Octreotide from Biodegradable Polymeric Microspheres. AAPS PharmSciTech 12:4, pages 1293-1301.
Crossref
Crossref
Holger Petersen, Jean-Claude Bizec, Helmut Schuetz & Marie-Laure Delporte. (2011) Pharmacokinetic and technical comparison of Sandostatin® LAR® and other formulations of long-acting octreotide. BMC Research Notes 4:1.
Crossref
Crossref
William H. Ludlam & Lowell Anthony. (2011) Safety review: Dose optimization of somatostatin analogs in patients with acromegaly and neuroendocrine tumors. Advances in Therapy 28:10, pages 825-841.
Crossref
Crossref
Jens Hasskarl, Martina Kaufmann & Herbert A Schmid. (2011) Somatostatin receptors in non-neuroendocrine malignancies: the potential role of somatostatin analogs in solid tumors. Future Oncology 7:7, pages 895-913.
Crossref
Crossref
Maria Fleseriu. (2010) Clinical efficacy and safety results for dose escalation of somatostatin receptor ligands in patients with acromegaly: a literature review. Pituitary 14:2, pages 184-193.
Crossref
Crossref
. (2011) Current World Literature. Current Opinion in Endocrinology, Diabetes & Obesity 18:1, pages 83-98.
Crossref
Crossref
Rao N. Jaladanki & Jian-Ying Wang. (2011) Regulation of Gastrointestinal Mucosal Growth. Colloquium Series on Integrated Systems Physiology: From Molecule to Function 3:2, pages 1-114.
Crossref
Crossref
Guo‐Cheng Han, Yang Ouyang, Xue‐Ying Long, Yu Zhou, Meng Li, You‐Nian Liu & Heinz‐Bernhard Kraatz. (2010) (Carboxymethyl–Dextran)‐Modified Magnetic Nanoparticles Conjugated to Octreotide for MRI Applications. European Journal of Inorganic Chemistry 2010:34, pages 5455-5461.
Crossref
Crossref
Lily P.H. Yang & Gillian M. Keating. (2010) Octreotide Long-Acting Release (LAR). Drugs 70:13, pages 1745-1769.
Crossref
Crossref
L. Van Nassauw & J.-p. Timmermans. (2010) Detailed knowledge of cellular expression of G protein-coupled receptors in the human enteric nervous system is essential for understanding their diverse actions. Neurogastroenterology & Motility 22:9, pages 959-964.
Crossref
Crossref